We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
-18.91%
1 Year Est. Return
-46.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
-$35.7M
Cap. Flow
-$4.31M
Cap. Flow %
-3.89%
Top 10 Hldgs %
28.98%
Holding
213
New
40
Increased
55
Reduced
31
Closed
62

Top Buys

Rank Stock Value
1
BCS icon
Barclays
BCS
+$4.41M
2
OEC icon
Orion
OEC
+$2.62M
3
KSS icon
Kohl's
KSS
+$1.63M
4
BXC icon
BlueLinx
BXC
+$1.32M
5
EEFT icon
Euronet Worldwide
EEFT
+$1.25M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$4.78M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$1.36M
3
TGLS icon
Tecnoglass
TGLS
+$1.27M
4
SPTN
SpartanNash
SPTN
+$1.16M
5
NWG icon
NatWest
NWG
+$1.07M

Sector Composition

Rank Sector Weight
1 Industrials 20.31%
2 Technology 20.16%
3 Consumer Discretionary 14.5%
4 Materials 11.96%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFII icon
101
TFI International
TFII
$12B
$341K 0.31%
4,243
-4,363
-51% -$355K
TASK icon
102
TaskUs
TASK
$531M
$340K 0.31%
+20,159
New +$514K
ONTF
103
DELISTED
ON24
ONTF
$337K 0.3%
+35,563
New +$431K
WDAY icon
104
Workday
WDAY
$36.4B
$334K 0.3%
2,394
-402
-14% -$73K
LEVI icon
105
Levi Strauss
LEVI
$9.83B
$326K 0.29%
+20,000
New +$361K
PD icon
106
PagerDuty
PD
$753M
$321K 0.29%
+12,963
New +$356K
S icon
107
SentinelOne
S
$6.22B
$315K 0.28%
+13,491
New +$379K
STTK icon
108
Shattuck Labs
STTK
$672M
$309K 0.28%
76,045
+17,206
+29% +$62.3K
CUE icon
109
Cue Biopharma
CUE
$137M
$307K 0.28%
4,105
+396
+11% +$46.3K
MNDY icon
110
monday.com
MNDY
$3.47B
$305K 0.28%
2,956
-198
-6% -$24.1K
SKIN icon
111
SkinHealth Systems
SKIN
$96.9M
$299K 0.27%
23,243
GFF icon
112
Griffon
GFF
$4.28B
$297K 0.27%
+10,589
New +$267K
BSX icon
113
Boston Scientific
BSX
$67.6B
$296K 0.27%
7,953
+484
+6% +$19.7K
HUBS icon
114
HubSpot
HUBS
$11.4B
$289K 0.26%
+962
New +$351K
ACCD
115
DELISTED
Accolade Inc
ACCD
$288K 0.26%
38,883
-9,145
-19% -$80K
TMUS icon
116
T-Mobile US
TMUS
$190B
$285K 0.26%
+2,121
New +$277K
RCKT icon
117
Rocket Pharmaceuticals
RCKT
$355M
$284K 0.26%
20,669
+5,456
+36% +$65K
ASO icon
118
Academy Sports + Outdoors
ASO
$3.09B
$283K 0.26%
7,951
-7,776
-49% -$285K
WHLRD
119
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$64.4M
$279K 0.25%
21,067
LDOS icon
120
Leidos
LDOS
$14.5B
$277K 0.25%
+2,752
New +$285K
MNSO icon
121
MINISO
MNSO
$3.72B
$273K 0.25%
34,798
+1,700
+5% +$11.6K
XOP icon
122
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.47B
$270K 0.24%
+2,264
New +$318K
ACVA icon
123
ACV Auctions
ACVA
$1.4B
$262K 0.24%
+40,000
New +$412K
ONEM
124
CALL
DELISTED
1Life Healthcare
ONEM
$256K 0.23%
+32,700
New +$281K
MCW
125
DELISTED
Mister Car Wash
MCW
$252K 0.23%
+23,121
New +$301K

Similar funds

Apogem Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Apogem Capital held 213 positions worth $111M, down 24% from $146M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Apogem Capital withdrew a net $4.31M in Q2 2022, closing 62 positions and reducing 31 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $1.36M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Apogem Capital opened a new position in Barclays worth $1.05M.

  • Apogem Capital's largest Q2 2022 buy was Barclays: 561,309 shares worth $1.05M.
  • Apogem Capital added most to Orion in Q2 2022, an estimated $2.62M increase.
  • Apogem Capital's biggest Q2 2022 reduction was Vodafone, cutting an estimated $4.78M.
  • Apogem Capital fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $1.36M.
  • Apogem Capital's ten largest holdings make up 29% of its $111M portfolio in Q2 2022.
  • Apogem Capital opened 40 new positions and closed 62 in Q2 2022.
  • Apogem Capital's portfolio value fell 24% quarter-over-quarter to $111M.

Based on Apogem Capital's 13F filing for Q2 2022, filed 15 Aug 2022.